《大行》花旗降高鑫零售(06808.HK)評級至「中性」 目標價升至2.35元
花旗研究報告指,高鑫零售(06808.HK)自5月公佈好過預期的業績後,股價一直表現強勁。管理層表示2026財年將優先推動銷售及毛利增長,但該行預期2026財年首季,即今年4至6月,銷售額將錄得中至高單位數按年跌幅,主要因平均售價下降,而價格壓力或來自電商平臺即時零售業務擴張的短期衝擊。
該行將2026及27財年的淨利潤預測各下調3%,銷售預測下調6%及7%。基於目前預期市盈率已反映營運效率改善帶來的業務復甦,評級由「買入」下調至「中性」,目標價由2.09元升至2.35元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.